Together, these findings predicate that future therapies aimed at depleting this multidrug-resistant CLL cell reservoir must simultaneously block multiple antiapoptotic proteins or activate Bax/Bak-independent apoptosis or induce nonapoptotic cell death. Here, BAK1 is linked to B-cell chronic lymphocytic leukemia.